Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.1000
+0.0020 (2.04%)
Aug 28, 2026, 10:15 AM AEST
Rhythm Biosciences Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -5.93 | -3.83 | -6.86 | -8.22 | -8.79 |
Depreciation & Amortization | 0.19 | 0.2 | 0.2 | 0.19 | 0.1 |
Loss (Gain) From Sale of Assets | -0 | - | - | - | - |
Stock-Based Compensation | 0.43 | 0.35 | -1.05 | 3 | 2.61 |
Other Operating Activities | 0.05 | -0 | - | - | - |
Change in Accounts Receivable | -0.02 | 0.38 | -1.03 | 0.91 | -0.48 |
Change in Inventory | 0.01 | 0.01 | 2.77 | -2.77 | - |
Change in Accounts Payable | 0.02 | - | - | - | - |
Change in Other Net Operating Assets | 0.02 | -0.04 | -0.16 | -0.08 | 0.07 |
Operating Cash Flow | -5.23 | -2.92 | -6.14 | -6.96 | -6.5 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.03 | -0.02 | -0.08 | -0.1 | -0.03 |
Sale of Property, Plant & Equipment | 0 | - | - | - | - |
Cash Acquisitions | - | -0.52 | - | - | - |
Other Investing Activities | - | -0.04 | - | - | - |
Investing Cash Flow | -0.02 | -0.58 | -0.08 | -0.1 | -0.03 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | - | 2.15 | - | - | - |
Total Debt Issued | - | 2.15 | - | - | - |
Short-Term Debt Repaid | -1.17 | -1.15 | - | - | - |
Long-Term Debt Repaid | -0.11 | -0.09 | -0.09 | -0.09 | -0.01 |
Total Debt Repaid | -1.27 | -1.24 | -0.09 | -0.09 | -0.01 |
Net Debt Issued (Repaid) | -1.27 | 0.91 | -0.09 | -0.09 | -0.01 |
Issuance of Common Stock | 9.03 | 3.5 | 3.02 | 3.74 | 12.32 |
Other Financing Activities | -0.54 | -0.22 | -0.12 | -0.02 | -0.47 |
Financing Cash Flow | 7.22 | 4.19 | 2.8 | 3.63 | 11.85 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | -0 | - | - | - | - |
Net Cash Flow | 1.96 | 0.69 | -3.41 | -3.43 | 5.32 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -5.26 | -2.94 | -6.22 | -7.06 | -6.52 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -302.10% | -92.25% | -367.98% | -227.94% | -268.74% |
Free Cash Flow Per Share | -0.02 | -0.01 | -0.03 | -0.03 | -0.03 |
Levered Free Cash Flow | -3.71 | -1.48 | -3.63 | -4.12 | -3.28 |
Unlevered Free Cash Flow | -3.67 | -1.43 | -3.63 | -4.12 | -3.28 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | - | 0.07 | 0 | 0.01 | - |
Cash Income Tax Paid | - | -3.17 | -1.69 | -3.08 | -2.41 |
Change in Working Capital | 0.03 | 0.36 | 1.57 | -1.93 | -0.41 |